Investors
Back to news & insights

Rebecca Fitzgerald 

Back to insights


23 May 2024

Share

More articles

Article

Companies
Epitopea advances potential ovarian cancer treatment

Press Release

Companies
Epitopea announces first patient dosed in OVACT Phase 1/1b clinical trial of CryptiVax™-1001 in advanced high-grade serous ovarian cancer


The Sovereign AI Summit 2026

Press Release

Companies
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease

Article

Companies
Cambridge’s T-Therapeutics raises $133m Series B to advance TCR therapies into the clinic

Article

Companies
Landmark gift puts Glasgow at forefront of robotic surgery

Video Watch

Companies
North East hospital helping to shape future of surgery with pioneering method

Press Release

CIC
Cambridge’s Innovation Hub and Oman’s Terminal 11 open a two-way bridge for startups

Article

Companies
Cambridge technology and life sciences companies attract almost $2.5 billion in stellar 12 months

Press Release

Read
Pretzel Therapeutics receives UK regulatory authorization to advance PX578 into clinical development in patients for the treatment of POLG-mediated primary mitochondrial disorders

To be first to hear news from CIC, its portfolio companies as well as opinion and analysis from our team, please sign up to our newsletter.
This field is for validation purposes and should be left unchanged.
Consent

PRI supports its international network of investor signatories to incorporate ESG into investment decisions and processes.

The Investing in Women Code is a commitment by financial services firms to the advancement of female entrepreneurship through improving female entrepreneurs’ access to tools, resources and finance.

CIC are supporters of BIA's Women in Biotech, a vibrant network that aims to improve the underrepresentation of women at senior levels in the biotech sector. Offering in-person events, an online forum, a range of guidance and a recently launched mentoring programme.

Cambridge Innovation Capital is a Carbon Neutral Business.

Purpose

  • Focus
  • Investment
  • EIR Programme

Commitment

  • Ecosystem
  • Impact & ESG
  • Values

Our People

  • Team
  • Board
  • Advisory Panel

Companies

  • Private
  • Acquired
  • IPO

News & insights

  • Insights
  • Events

Information

  • Contact

Legal

  • Terms of use
  • Privacy
  • Cookie policy
  • Cookie preferences policy

News & insights

  • Insights
  • Events

Information

  • Contact

Legal

  • Terms
  • Privacy Policy
  • Cookie Policy
  • Cookie preferences policy

© 2026 Cambridge Innovation Capital. All rights reserved

Cambridge Innovation Capital Manager Limited (FRN:918898) is authorised and regulated by the Financial Conduct Authority.

  • Home
  • Purpose
    • Focus
    • Investment
    • EIR Programme
    • Accelerators
  • Commitment
    • Ecosystem
    • Impact & ESG
    • Values
  • Team
  • Companies
  • News & Insights
    • Insights
    • Events
  • Contact

© 2025 Cambridge Innovation Capital.
All rights reserved

Terms | Privacy | Cookie Policy | Cookie Preferences

Tell us whether you accept cookies
We use cookies to collect information to improve the performance of our website. To find out more about the type of cookies we use and how we use this information please review our cookie policy page. Alternatively, you can manage your cookie preferences by clicking Cookie settings.
Functional cookies Always active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. Without these cookies, some parts of our site or the service being requested will be impossible to provide.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Functional Cookies
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Analytics
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Cookie settings
  • {title}
  • {title}
  • {title}